Laboratory News and Research

RSS

Grizzly bears' strategy could help prevent muscle atrophy in humans

Grizzly bears spend many months in hibernation, but their muscles do not suffer from the lack of movement. In the journal "Scientific Reports", a team led by Michael Gotthardt reports on how they manage to do this.

30 Dec 2019

A new deep learning approach to predict disease-associated mutations

During the past years, artificial intelligence (AI) -- the capability of a machine to mimic human behavior -- has become a key player in high-techs like drug development projects.

28 Dec 2019

New 'fishing' technique to detect thousands of proteins

A new study published today in the journal Nature Cell Biology reports the use of a novel fishing method, under microscopy, to pick up thousands of proteins that are involved in supervising how the cell skeleton is assembled.

23 Dec 2019

New technique provides real-time images of biomolecules in living cells

Metabolic diseases such as diabetes and obesity are ever more common globally. In addition to genetic disposition, lifestyle contributes strongly to the prevalence of these metabolic diseases.

23 Dec 2019

Autism risk in children could be predicted by mutations in paternal sperm

Researchers from the University of California, San Diego, have found that mutations present in the sperms of the father could be predictors of autism in the offspring, in a landmark study. These mutations, if quantified could help ascertain the risk say the researchers. The new study appears this week in the latest issue of the journal Nature Medicine.

23 Dec 2019

Scientists develop 3D atlas of bone marrow to help study blood diseases

The bone marrow, which is the spongy and viscous tissue that fills the bone, is the site of blood cell formation or hematopoiesis. If the bone marrow doesn’t work properly, it can lead to many blood diseases, including leukemia, sickle cell anemia, and lymphoma, among others.

23 Dec 2019

NFCR-funded translational cancer research project receives $700,000 from Virginia Catalyst

A translational research project supported by the National Foundation for Cancer Research (NFCR) has been awarded $700,000 from Virginia Catalyst to advance its lead cancer drug candidate.

23 Dec 2019

2,500 vaping-related hospitalizations in the US

Over the past few months, there was a sudden surge of patients presenting with mysterious lung disease, e-cigarette, or vaping, product use-associated lung injury (EVALI), which was tied to e-cigarette use. Now, the Centers for Disease Control and Prevention (CDC) reports more than 2,500 hospitalizations and a total of 54 deaths.

22 Dec 2019

MIT engineers generate first laser ultrasound images in humans

For most people, getting an ultrasound is a relatively easy procedure: As a technician gently presses a probe against a patient's skin, sound waves generated by the probe travel through the skin, bouncing off muscle, fat, and other soft tissues before reflecting back to the probe, which detects and translates the waves into an image of what lies beneath.

21 Dec 2019

McGill study finds new role of apolipoprotein E4 gene in Alzheimer’s disease

For years, physicians have been aware that patients carrying the apolipoprotein E4 (APOEε4) gene are at a greater risk of developing Alzheimer's disease. New research from McGill University has now found the gene plays an even greater role in dementia.

21 Dec 2019

Scientists successfully cultivate and characterize corpus luteum cells of cats

The reproduction of lynxes is highly mysterious. Unlike other wild cats, most lynxes are only receptive for a few days once a year.

20 Dec 2019

Artificial intelligence can detect AML with high reliability

Artificial intelligence can detect one of the most common forms of blood cancer - acute myeloid leukemia (AML) - with high reliability.

20 Dec 2019

Kobe scientists develop mathematical model to predict cancer drug side effects

A research team at Kobe University Hospital have further illuminated the likelihood of cancer drug side effects that can occur due to genetic mutations in the drug-metabolizing enzyme.

20 Dec 2019

Researchers locate brain biomarkers for detecting Alzheimer's disease

From the detection of functional brain changes that occur during Alzheimer's Disease, a research team from the Complutense University of Madrid has located a set of biomarkers that could predict which patients with Mild Cognitive Impairment have a higher risk of developing dementia.

20 Dec 2019

Combined datasets can expedite the discovery and development of new cancer drugs

A comprehensive map of genes necessary for cancer survival is one step closer, following the validation of the two largest CRISPR-Cas9 genetic screens in 725 cancer models, across 25 different cancer types.

20 Dec 2019

Jefferson researcher probes kidney cancer's genes for interactions with p53 pathway

p53 is the most famous cancer gene, not least because it's involved in causing over 50% of all cancers. When a cell loses its p53 gene -- when the gene becomes mutated -- it unleashes many processes that lead to the uncontrolled cell growth and refusal to die, which are hallmarks of cancer growth.

20 Dec 2019

Aarhus University to open new research center focusing on Ear-EEG technology

Researchers at the Department of Engineering are world leaders in brain measurement via a special device fitted in the ear like a hearing aid.

20 Dec 2019

The brain’s temporal lobe is also an attention controlling area, shows study

As you read this line, you're bringing each word into clear view for a brief moment while blurring out the rest, perhaps even ignoring the roar of a leaf blower outside.

19 Dec 2019

Nanopores – the key to identifying amino acids in proteins

DNA and RNA sequencing has become the new watchword for the biological researchers, as this tells them exactly what is going on at cellular level in health and disease. However, it is a partial revelation unless we also know what is happening at the level of proteins as well.

19 Dec 2019

New antibody shows promise in active lupus

A new trial involving the use of an antibody called anifrolumab reports improvement in patients with systemic lupus erythematosus (SLE) after 52 weeks of treatment. The research, titled 'Trial of Anifrolumab in Active Systemic Lupus Erythematosus', is published in the New England Journal of Medicine.

19 Dec 2019